Medi Stone

Medi joined the systematic review team at Mtech Access in 2019 after completing her BSc in pharmacology at the University of Bristol. She became interested in Market Access while writing her dissertation on ketamine versus other NMDA antagonists as antidepressants: a systematic review and meta-analysis. Medi contributes to the systematic review process across a range of therapeutic areas by developing study protocols, undertaking publication screening and data extraction, and report writing.